Cargando…
Concomitant bilastine and montelukast as additive therapy for seasonal allergic rhinoconjunctivits and mild‐to‐moderate asthma. The SKY study
Autores principales: | Lavorini, Federico, Matucci, Andrea, Rossi, Oliviero, Pistolesi, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078869/ https://www.ncbi.nlm.nih.gov/pubmed/31376160 http://dx.doi.org/10.1111/all.14007 |
Ejemplares similares
-
Green quality by design HPLC approach for the simultaneous determination of Bilastine and Montelukast
por: Roshdy, Aya, et al.
Publicado: (2023) -
Bilastine for allergic rhinoconjunctivitis, urticaria
Publicado: (2022) -
Role of Montelukast in Asthma and Allergic rhinitis patients
por: Zuberi, Faisal Faiyaz, et al.
Publicado: (2020) -
Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria
por: Sadaba, Belen, et al.
Publicado: (2013) -
Corticosteroid reduction by addition of cetirizine and montelukast in biopsy-proven minimal-change nephrotic syndrome concomitant with allergic disorders
por: Oshima, Yoichi, et al.
Publicado: (2020)